Interview with Dr. Thomas Costa of Coventya
By Humatica
In the new episode of the alpha Talks Podcast, Enno Krey speaks to Dr. Thomas Costa, former CEO of Coventya (acquired by MacDermid Enthone in 2021), a leading international specialty chemicals company. Thomas has successfully led Coventya through 20 years of PE ownership before it was acquired by Element Solutions Inc (NYSE:ESI) this year.
Thomas speaks about his journey and the lessons learnt as a successful Private Equity CEO.
Listen to the podcast:
You can subscribe to the podcast on Spotify:
alpha Talks is the podcast dedicated to Private Equity value growth. Enno speaks to experienced buyout CEOs, operating partners, deal makers and advisors about their experience and lessons-learned in the industry.
Related Insights
The CFO’s AI Imperative: From Efficiency Gain to Strategic Transformation
Finance has always been an early adopter of technology — from double-entry bookkeeping to spreadsheets to ERP to cloud-based analytics. And finance has always been…
Read more
Building the AI-Ready Organisation: Why Technology is the Easiest Part
When most organisations begin an AI readiness assessment, they start with technology. Do we have a modern cloud infrastructure? A unified data platform? Access to…
Read more
The AI Workforce Paradox: More Productivity, More Uncertainty, and a Generation of Workers Who Don’t Know Where They Stand
The evidence that AI improves individual productivity is now overwhelming. Across dozens of controlled studies, knowledge workers with AI tools consistently outperform those without —…
Read more
Subscribe to our Monthly Newsletter and other News Updates
Receive our news and valuable perspectives on organizational effectiveness each month.
